Compare Novavax Inc (NVAX) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Paychex, Inc. — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while Paychex, Inc. trades at $115.19 (market cap $40.98B). The key difference: Paychex, Inc. is far larger — about 31.5× Novavax Inc's market cap, and Paychex, Inc. pays a 4.13% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | PAYX | |
|---|---|---|
Market Cap | $1.30B | $40.98B |
Sector | Health | Industrials |
52-Week High | $11.19 | $147.99 |
52-Week Low | $6.22 | $85.57 |
Enterprise Value | $800.50M | $44.47B |
Dividend Yield | — | 4.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
